As DNL in the liver is directly stimulated by insulin, subjects with hyperinsulinemia will accumulate liver fat more readily than others and so contribute to the development of metabolic (dysfunction)-associated fatty liver disease (MAFLD) (formerly called nonalcoholic fatty liver disease (NASH)) [66,120]. The gene discussed is INS; the disease is hyperinsulinism.